ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Endonovo Therapeutics Inc (PK)

Endonovo Therapeutics Inc (PK) (ENDV)

0.00025
-0.00005
(-16.67%)
Closed April 19 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

ENDV News

Official News Only

ENDV Discussion

View Posts
Biotech_Tradez Biotech_Tradez 3 weeks ago
I wonder how many shares Trillium has converted at $0.00005 and sold to these suckers.

Forget about the 2's, people bought at 3 and thought it was going up more not realizing that there is a diluter converting at $0.00005 and dumping into the volume.

My take is these idiots deserve what they get because they didn't even bother to read the sticky on the stock to know why it is this "cheap," or read the annual report to know that the company has no cash, no assets, and no revenue.

Also, OTCMarkets has placed a "SHELL RISK" warning on the ticker symbol because it has all the characteristics of a shell company, i.e. no assets, revenue and limited filings.
👍 1
Craig305 Craig305 3 weeks ago
All the people that bought the 2s are trapped. They were not able to sell at 3 and now 2s are back on the Ask. They may have to take a 50% loss or hope that a new pump can buy their 2s back for break even. 
👍️0
Biotech_Tradez Biotech_Tradez 4 weeks ago
New pump and dump crew buying up all the dilution. GLTA
👍️0
firebag1 firebag1 4 weeks ago
ADDED TOO - GLTYA
👍️0
Biotech_Tradez Biotech_Tradez 4 weeks ago
OTC Markets has added a "Shell Risk" to this ticker.

No assets tons of liabilities, faint disclosure and no revenue.
👍️0
Rainer Rainer 4 weeks ago
added... GLTA
👍️0
Biotech_Tradez Biotech_Tradez 4 weeks ago
1.2 billion O/S and looks like they are selling them!
👍️0
ScambusterBrown ScambusterBrown 1 month ago
Don't give all the credit to Alan Collier. His partner in crime is Garry Kann aka Garry Michael Kann who lost his broker license years ago, filed bankruptcy, defrauded investors, and has been running scams on both coasts since the early 1990s under many business names. Collier and Kann are two cons in a pod. They should be in prison for the level of fraud they have perpetrated.
👍 1
Biotech_Tradez Biotech_Tradez 1 month ago
"The company has or shortly will have judgements totaling approximately $400,000"

Expect more dilution to pay for these new lawsuits they are going to lose.

$3 in the bank, no real assets and 20 million in liabilities.
👍️0
Craig305 Craig305 1 month ago
Annual report released.
$0 sales in Q4. Total annual sales in 2024 was $10K
The 8-K with Evermed assisting with sales was supposed to bring in $168K in 2024.
The deal with Evermed appears to be non-existent.
👍️0
Craig305 Craig305 1 month ago
The Annual report is now released. You can see the conversion of the shares at .00005. Yikes. It will take Billions upon Billions of shares to repay the settlement.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
160 million shares converted this week.

New O/S is 1,097,921,313

Not long until they run out of shares to print and have to reverse the stock again.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
LOL, PATHETIC ATTEMPT TO KEEP THE STOCK AFLOAT.

Hundreds of millions of shares have probably been converted at $0.00005 and are being dumped, per the lawsuit they lost.

Funny how they don't put out bad news in PR's and 8K's but rather bury it in the footnotes of their financials.

This company is going into bankruptcy, it has no money to do anything, its bank account was overdrawn in its last quarterly report. The CEO has been fleecing shareholders for about a decade now and has never accomplished anything that has resulted in shareholder value. Their spin out is dead because they have no way to justify a bloated valuation let alone convince investors to put up north of $15 million to meet the initial listing requirements on NASDAQ.

This stock is going to need a reverse stock split pretty soon based on the rate of conversions and dilution.

This is basically the CEO going on another pump scheme to keep from having to shut this piece of shit down and go out and get a real job.
👍️0
Rainer Rainer 2 months ago
$ENDV Thank you to all our shareholders for your continued support.

We have several important updates coming which will be released as soon as possible via PR’s and 8k’s.— Endonovo Therapeutics, Inc. (@EndonovoInc) February 27, 2025
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
BUYER BEWARE: BIG CONVERSIONS AT $0.00005 UPCOMING!!

My target price of $0.0001 (Par Value) has been hit and now conversions will be done at below par value!

We may have massive dilution next week.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
84.5 Million shares added last week! Yikes!!!

938,237,313 shares outstanding. Looks like the fire sale at ENDV continues. Not long before this thing hits the floor.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
And here we go!! 90 million shares dumped on the bid.

RUN!!!!!!
👍️0
Closerlook Closerlook 2 months ago
The sub-penny OTC market is dying. Program buys and sells make it look like something is here but everyone is moving to crypto.
👍️0
Biotech_Tradez Biotech_Tradez 2 months ago
70 Million shares added this week!

New O/S is 853,720,313. Expect some big dumps on the bid next week.

Collier is awful quiet about his penny stock scam circling the drain. He can't even think up a new lie to pump his stock price anymore. That or like I stated, he wants it to tank so that he can give himself a bonus and screw his investors over once and for all before he reverses the stock.
👍️0
Craig305 Craig305 2 months ago
We have been telling you....they lost a lawsuit....Billions will be diluted. 
The strongest trouts could not swim upstream against the dilution that will be continuing for some time.
👍️0
Alley-oop Alley-oop 2 months ago
Shits are diluting this.
👍️0
brojazzy brojazzy 3 months ago
Ouch, this "stock" is dog shit, is mgmt in prison yet?
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
BUYER BEWARE: New Target Stock Price is $0.0001

Given that Trillium has the ability to convert at 50% discount to market their next conversions will be at $0.0001 or par value. As was predicted in my post below, the market price converges toward the conversion price and following conversions is driven down 50%, essentially it is a death spiral.

My other warning is that this company only has 2.5 billion authorized shares and is already at north of 800 million shares before we get conversions. I also want to point out that I have a very strong hunch that the CEO will give himself a massive bonus in the form of shares as soon as the stock price reaches par value ($0.0001). I predict somewhere in the neighborhood of $50,000 of stock at par value or 500 million shares before he decides to reverse the stock and repeat this scam as he has already done this to shareholders.

So my warning and predictions are as follows:

1.) Stock price goes to $0.0001 or less
2.) CEO gives himself a large bonus at par value or less (maybe 500 million shares)
3.) Reverse stock split at 1 for 1,000 like the last time.

You have been warned. Please feel free to post this as a sticky.
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
LOL, thanks for letting us know your opinions will only be to pump the stock.
💯 1
Alley-oop Alley-oop 3 months ago
That is really good news. Who cares if the company is bankrupt or not. It is already trading low. 
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
This company is heading for bankruptcy, RUN!!!!
💯 1
Alley-oop Alley-oop 3 months ago
Good job!
👍️0
Craig305 Craig305 3 months ago
97 Million shares added to the float in the past week. 
22% increase. 
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
LOL, you can't make this shit up!
👍️0
Craig305 Craig305 3 months ago
Are you aware that ENDV lost a lawsuit and there will be a minimum of 4 Billion shares added to the float?  The plantiff will just unload their shares on a high volume day.
It will be extremely difficult for this to have any significant rise in SP.
💯 1
Gladiator 83 Gladiator 83 3 months ago
Now it's time for good news.
👍️0
Craig305 Craig305 3 months ago
Since you are keeping watch on the share structure, you will notice that from Jan 3 to Jan 10, the unrestricted shares increased by 86 million shares. An increase of 24% in just 1 week. 😯 
👍️0
Gladiator 83 Gladiator 83 3 months ago
Are they going to get any positive news?
👍️0
Craig305 Craig305 3 months ago
Do you work for Trillium to help promote the stock to assist with making a market for them to dump their shares?
👍️0
Craig305 Craig305 3 months ago
This is certainly not the bottom. If you believe it is, consider it will remain at the bottom until Trillium sells their 4 - 7 Billion shares. 
They will dump their shares into any attempted rally. 
Do you realize the authorized shares is only 2.5 Billion? That is not enough room for Trillium to unload their shares. If ENDV does not increase the A/S, this will surely reverse split and then continue to fall as Trillium dumps shares to get their money.
Please explain how this is a good investment at the current time?
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
LOL! Completely clueless. Doesn't understand markets.
👍️0
Alley-oop Alley-oop 3 months ago
Do you guys work for MMs? 
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
LOL! Still trying to convince others to buy this scam.

This belongs in Bankruptcy Court not on the pink sheets. The balance sheet is a disaster.
👍️0
Alley-oop Alley-oop 3 months ago
If you believe it, please you don't buy it. Who cares this is already bottom.
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
No end in sight to this dilution...
👍️0
Craig305 Craig305 3 months ago
If anyone does not believe the $2.9 million settlement as being real, you can see it posted on OTC Markets by ENDV themselves.
https://www.otcmarkets.com/stock/ENDV/disclosure

👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
And magically he disappeared!
😂 2
Craig305 Craig305 3 months ago
What do you have to say about Case No CACE24009960?  The court issued an order approving a settlement of $2,896,956.15 of the Company’s outstanding debt in 
exchange for the issuance of shares. The shares will be free of any restriction and be marketable securities.
Billions of shares will be diluted based on current SP.
😂 1
Biotech_Tradez Biotech_Tradez 3 months ago
LOL, trying too hard to fish for suckers!
👍️0
Alley-oop Alley-oop 3 months ago
$ENDV NO OS CHNAGE

ENDV Security Details
Share Structure
Market Cap Market Cap
435,097 01/03/2025
Authorized Shares
2,500,000,000 01/03/2025
Outstanding Shares
543,871,313 01/03/2025
Restricted
195,293,179 01/03/2025
Unrestricted
348,578,134 01/03/2025
👍️0
Alley-oop Alley-oop 3 months ago
The record date is crucial for determining eligibility, but as of now, no official record date for the SofPulse dividend has been announced in public statements.
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
They will fund all those things with their overdrawn bank account and zero sales for last quarter! LOL!

Give us a break.
👍️0
GetSeriousOK GetSeriousOK 3 months ago
Thanks! one last question:

How do they determine which ENDV shareholders get the stock dividend? Is it "shareholders as of a certain date," and if so, what is that date?
👍️0
Alley-oop Alley-oop 3 months ago
Summary of Endonovo’s Restructured Business Model

Focus on Digital Health and AI Integration:

Endonovo Therapeutics (ENDV) is reorganizing to develop an integrated AI-powered digital healthcare and wellness platform.
The platform aims to enhance patient engagement, streamline access for healthcare providers, and expand retail sales of wellness and medical products.

Expansion into the Wellness Market:

ENDV is entering the $4.3 trillion global wellness market (projected to reach $7 trillion by 2025) with a focus on e-commerce.
Its platform will feature AI-integrated e-commerce for wellness products, including the company’s Pulsed Electro Magnetic Field (PEMF) multi-coil technology.

Market Potential and AI Differentiation:

The digital health market, valued at $375.99 billion in 2022, is projected to grow to $1.965 trillion by 2030 at a CAGR of 23.3%.
ENDV's AI integration will provide advanced analytics, predictive marketing, and enhanced customer engagement, setting its platform apart from competitors.

Strategic Goals:

Transform patient care across medical and wellness industries.
Utilize AI for better insights into customer behavior, targeted marketing, and efficient customer support.

Company Structure:

Digital Health and Wellness Division: Focused on the AI-powered platform and e-commerce marketplace.
Legacy Division: Developer of non-invasive wearable Electroceutical® devices for general wellness.
👍️0
Biotech_Tradez Biotech_Tradez 3 months ago
LOL! Repeating the same BS as the last pump and dumper!

This company's contraption doesn't work like they said it did. It lacks real studies. All their scientists left to start their own competitor company as Craig previously posted. They originally were going to acquire this technology for $28 million, then sued and bought it for $4.5 million which is probably what it was worth and proceeded to destroy all its value by proving they couldn't sell the product, dropping the concussion studies, and suing their competitors and failing. So, how on God's green earth is the valuation supposed to suddenly increase over 10x what they paid for it? I guess they plan to sprinkle fairy dust on it.

It has been a year and they still have not gotten it done, guess why? Nobody will issue a valuation for them because they could get sued. Nobody is going to finance it to go onto NASDAQ. It takes around $10 million to get on. Lastly, the debt holders will be the fist to dump the shares in order to get their money, which they will convert to freely traded shares long before any retail investor can. This is another one of the CEO's scams to keep milking money out of investors.
👍️0